APO-RIVASTIGMINE PATCH 15 rivastigmine 13.3 mg/24 hours transdermal drug delivery system sachet Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

apo-rivastigmine patch 15 rivastigmine 13.3 mg/24 hours transdermal drug delivery system sachet

arrotex pharmaceuticals pty ltd - rivastigmine, quantity: 27 mg - drug delivery system, transdermal - excipient ingredients: acrylates copolymer; ethyl acetate; hexane; 2-ethylhexyl acrylate; methyl acrylate; acrylic acid; acrylates/ethylhexyl acrylate copolymer; methylated trimethylated silica - apo-rivastigmine patch is indicated for the treatment of patients with mild, moderate and severe dementia of the alzheimer?s type.

APO-RIVASTIGMINE PATCH 5 rivastigmine 4.6 mg/24 hours transdermal drug delivery system sachet Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

apo-rivastigmine patch 5 rivastigmine 4.6 mg/24 hours transdermal drug delivery system sachet

arrotex pharmaceuticals pty ltd - rivastigmine, quantity: 9 mg - drug delivery system, transdermal - excipient ingredients: acrylates copolymer; ethyl acetate; hexane; 2-ethylhexyl acrylate; methyl acrylate; acrylic acid; acrylates/ethylhexyl acrylate copolymer; methylated trimethylated silica - apo-rivastigmine is indicated for the treatment of patients with mild to moderate dementia of the alzheimer's type.

APO-RIVASTIGMINE PATCH 10 rivastigmine 9.5 mg/24 hours transdermal drug delivery system sachet Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

apo-rivastigmine patch 10 rivastigmine 9.5 mg/24 hours transdermal drug delivery system sachet

arrotex pharmaceuticals pty ltd - rivastigmine, quantity: 18 mg - drug delivery system, transdermal - excipient ingredients: acrylates copolymer; ethyl acetate; methylated trimethylated silica; hexane; 2-ethylhexyl acrylate; methyl acrylate; acrylic acid; acrylates/ethylhexyl acrylate copolymer - apo-rivastigmine is indicated for the treatment of patients with mild to moderate dementia of the alzheimer's type.

MED-RIVASTIGMINE CAPSULE Kanada - Kiingereza - Health Canada

med-rivastigmine capsule

generic medical partners inc - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 1.5mg - rivastigmine (rivastigmine hydrogen tartrate) 1.5mg - parasympathomemetic (cholinergic) agents

MED-RIVASTIGMINE CAPSULE Kanada - Kiingereza - Health Canada

med-rivastigmine capsule

generic medical partners inc - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 3mg - rivastigmine (rivastigmine hydrogen tartrate) 3mg - parasympathomemetic (cholinergic) agents

MED-RIVASTIGMINE CAPSULE Kanada - Kiingereza - Health Canada

med-rivastigmine capsule

generic medical partners inc - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 4.5mg - rivastigmine (rivastigmine hydrogen tartrate) 4.5mg - parasympathomemetic (cholinergic) agents

MED-RIVASTIGMINE CAPSULE Kanada - Kiingereza - Health Canada

med-rivastigmine capsule

generic medical partners inc - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 6mg - rivastigmine (rivastigmine hydrogen tartrate) 6mg - parasympathomemetic (cholinergic) agents

RATIO-RIVASTIGMINE CAPSULE Kanada - Kiingereza - Health Canada

ratio-rivastigmine capsule

teva canada limited - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 1.5mg - rivastigmine (rivastigmine hydrogen tartrate) 1.5mg - parasympathomemetic (cholinergic) agents

RATIO-RIVASTIGMINE CAPSULE Kanada - Kiingereza - Health Canada

ratio-rivastigmine capsule

teva canada limited - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 3mg - rivastigmine (rivastigmine hydrogen tartrate) 3mg - parasympathomemetic (cholinergic) agents

RATIO-RIVASTIGMINE CAPSULE Kanada - Kiingereza - Health Canada

ratio-rivastigmine capsule

teva canada limited - rivastigmine (rivastigmine hydrogen tartrate) - capsule - 4.5mg - rivastigmine (rivastigmine hydrogen tartrate) 4.5mg - parasympathomemetic (cholinergic) agents